Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia

South African Journal of Psychiatry


 
 
Field Value
 
Title Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia
 
Creator Benelmokhtar, Jebril M. Chiliza, Bonginkosi Phahladira, Lebogang Emsley, Robin Asmal, Laila
 
Subject Psychiatry adherence; schizophrenia; first episode; dual diagnosis; flupenthixol decanoate; long acting injectable; positive and negative syndrome scale
Description Background:Prevention of new episodes during the first 2 years after a first episode of schizophrenia (FES) may delay treatment refractoriness and brain morphological changes over time. However, adherence to treatment is characteristically poor in these patients.Aim: The aim of this study was to examine clinical and sociodemographic factors associated with patient dropout in patients with FES.Setting: This study was set at inpatient and outpatient services at a psychiatric hospital in the Western Cape, between 2007 and 2011.Methods: Data were collected as part of a prospective longitudinal study, which followed up patients with FES treated with flupenthixol decanoate. We examined the relationship between treatment adherence and sociodemographic and clinical factors at baseline and at 24 months. Unadjusted and adjusted logistic regression models were used to determine adherence variables.Results: A total of 62% of patients completed the 24 months of treatment. Participants with FES and a substance use disorder (dual diagnosis) were at greater risk of dropout (p = 0.01). On univariate analysis, dual diagnosis participants who dropped out were older (p = 0.04) had completed more years of schooling (p = 0.001), older age of onset (p = 0.02) and higher baseline positive symptoms (p = 0.05). On regression analysis, non-completer substance users achieved a higher level of education (odds ratio [OR]: 3.87, confidence interval [CI]: 1.34–11.11, p = 0.01).Conclusion: Substance use disorder was associated with non-adherence to follow up in a cohort of FES patients treated with flupenthixol decanoate. Interventions that take into account age, education and baseline positive symptoms may afford the opportunity to influence adherence and patient outcome.
 
Publisher AOSIS
 
Contributor New Partnership for Africa’s Development (NEPAD) Medical Research Council of South Africa Lundbeck International
Date 2021-03-09
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — prospective longitudinal study
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajpsychiatry.v27i0.1657
 
Source South African Journal of Psychiatry; Vol 27 (2021); 7 pages 2078-6786 1608-9685
 
Language eng
 
Relation https://sajp.org.za/index.php/sajp/article/view/1657/2018 https://sajp.org.za/index.php/sajp/article/view/1657/2017 https://sajp.org.za/index.php/sajp/article/view/1657/2019 https://sajp.org.za/index.php/sajp/article/view/1657/2016
 
Coverage Africa; South Africa; Western Cape 2007 and 2011 male or female subjects age 16 to 45, with first episode of psychosis
Rights Copyright (c) 2021 Jebril M. Benelmokhtar, Bonginkosi Chiliza, Lebogang Phahladira, Robin Emsley, Laila Asmal https://creativecommons.org/licenses/by/4.0